NCT01713387View on ClinicalTrials.gov

A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

March 31, 2017

Conditions
Biliary Tract Cancer
Interventions
DRUG

Gemcitabine, S-1

Dose of gemcitabine and S-1 and treatment schedule

Trial Locations (1)

573-1191

Kansai Medical University, Hirakata

All Listed Sponsors
lead

Kansai Hepatobiliary Oncology Group

NETWORK

NCT01713387 - A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy | Biotech Hunter | Biotech Hunter